CASP3, caspase 3, 836

N. diseases: 819; N. variants: 26
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE We have previously demonstrated that restoration of DLC1 tumor suppressor gene expression in the DLC1-negative Focus and 7703K human hepatocellular carcinoma (HCC) cell lines induced caspase-3 mediated apoptosis, reduced cell growth in vitro and tumorigenicity in vivo and diminished the ability to migrate through Matrigel, a property suggestive of metastatic potential in vivo. 18497990 2008
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE Although we recently demonstrated that cytoplasmic AFP might interact with caspase-3 and inhibit the signal transduction of apoptosis in human hepatocellular carcinoma (HCC) cells, the details of this interaction are not clear. 28653316 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. 18949401 2008
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE The variation of circulating miR-221 levels in relation to Sorafenib treatment were assayed in the animal models and in two independent cohorts of patients with advanced HCC.<b>Results:</b> MiR-221 over-expression was associated with Sorafenib resistance in two HCC animal models and caspase-3 was identified as its target gene, driving miR-221 anti-apoptotic activity following Sorafenib administration. 28096271 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE An elevation in serum level of the inflammatory (TNF-ά, CRP, and Argenase), hepatic apoptotic markers (P53, Bax, and Caspase 3) and a reduction of Blc2% were recorded in HCC rats. 28821164 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE CCK-8, EdU, transwell, western blot and caspase-3 activity analyses were utilized to testify the role of LINC00467 in HCC. 31656043 2020
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE Further studies also indicated that SEPT2 promoted HCC cell growth via upregulation of matrix metalloproteinase (MMP)-2 and -9, and simultaneously inhibited the cleavage of caspase-3, -7, and -9. 25592041 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE TUNEL assay revealed that resveratrol induced cell apoptosis by increasing HCC apoptosis rate from 3±0.78% to 16±1.12% with upregulation of B‑cell lymphoma (Bcl)‑2 associated X, apoptosis regulator and cleaved‑poly (ADP‑Ribose) polymerase 1 (PARP), and downregulation of Bcl‑2, caspase‑3, caspase‑7 and PARP. 28983625 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE Furthermore, Chrysin was able to increase caspase-3 activity in the HCC rats group (about 2.4 fold) compared to the normal rats group. 31708277 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE The induction of HCC cell apoptosis by UDCA was dose-dependent and time-dependent and was mediated by the regulation of Bax to Bcl-2 ratio, the expressions of Smac and Livin, and caspase-3 expression and activity. 25214410 2014
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE Finally, we found that inhibition of p38 by SB202190 abrogated enhanced hepatocyte death, compensatory proliferation and HCC induced by DEN in Caspase-3-deficient mice. 29752472 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE In addition to melanoma, the DGKα inhibitors enhanced caspase 3/7 activity and reduced the viability of hepatocellular carcinoma, glioblastoma, and pancreatic cancer cells, but not breast adenocarcinoma cells. 30536880 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE Interestingly, MK-AS also clearly downregulated the protein level of Bcl-2, and upregulated p53, Bax, and caspase-3 in the hepatocellular carcinoma tissue. 17303011 2007
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE In contrast, here we demonstrated apoptosis induction in human lung epithelial carcinoma (A549), human hepatocarcinoma and Vero cells upon infection with the attenuated Candid#1 strain of, JUNV as determined by phosphatidylserine (PS) translocation, Caspase 3 (CASP3) activation, Poly (ADP-ribose) polymerase (PARP) cleavage and/or chromosomal DNA fragmentation. 24918927 2014
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE The objective of this study was to investigate the effect of Solanum nigrum polysaccharides (SNPs) on tumor growth in H22 hepatocarcinoma cells bearing mice and explore the mechanism by focusing on the regulation of the expression of caspase-3 and bcl-2. 29578179 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE Yellow fever virus modulates cytokine mRNA expression and induces activation of caspase 3/7 in the human hepatocarcinoma cell line HepG2. 30725182 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE MiR-30a-5p mimic markedly inhibited cell growth, also induced caspase-3/7 activity and apoptosis in all four HCC cell lines tested. 26884832 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE SCL2A9 induced HCC cell apoptosis by inhibiting the expression of caspase 3. 29523220 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE HBV-related HCC demonstrated significantly suppressed caspase-3 activity, signifying apoptosis. 12632104 2003
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE Effects of GTN were evaluated by the flow cytometry, alkaline comet assay, immunocytochemistry, small-hairpin RNA interference, mitochondria/cytosol fractionation, quantitative reverse transcription-polymerase chain reaction, immunoblotting analysis and caspase 3 activity assays in two HCC-derived cell lines. 21810437 2011
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 AlteredExpression disease BEFREE The result confirmed that the HCC condition was developed in response to lower expressions of caspase 3 and 9 which, in turn, was due to the upstream regulation of iNOS, Bcl-xl and Bcl-2, and downstream regulation of eNOS, BAX, BAD and Cyt C. The treatment with ZOL caused the significant activation of caspase mediated apoptotic signals that could be responsible for its anti-HCC potential. 31129132 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE Plumbagin promotes human hepatoma SMMC-7721 cell apoptosis via caspase-3/vimentin signal-mediated EMT. 31409969 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE These results suggested that PPW-induced apoptosis involved a caspase-3-mediated mitochondrial pathway and may have potential as a cancer chemopreventive and therapeutic agent for the prevention and treatment of HCC. 26555544 2016
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 Biomarker disease BEFREE Furthermore, downregulation of PHLDA gene, upregulation of ACIN1 protein and caspase-3 activation in exposed cells indicated that endosulfan can trigger apoptotic cascade in hepatocellular carcinoma cells. 26615145 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.300 GeneticVariation disease BEFREE These results suggest that the CASP3 rs12108497 polymorphism may play a role in the development of HCC among smoking individuals in the Chinese population. 26758428 2016